ketoprofen and nalbuphine

ketoprofen has been researched along with nalbuphine in 11 studies

Research

Studies (11)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (9.09)	18.2507
2000's	9 (81.82)	29.6817
2010's	1 (9.09)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Andricopulo, AD; Moda, TL; Montanari, CA	1
Strassburg, CP; Tukey, RH	1
Topliss, JG; Yoshida, F	1
Johans, C; Kinnunen, PK; Söderlund, T; Suomalainen, P	1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Lombardo, F; Obach, RS; Waters, NJ	1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Buzelin, JM; Cozian, A; Le Normand, L; Lepage, JY; Malinge, M; Malinovsky, JM; Pinaud, M	1
Boissinot, C; Jacqz-Aigrain, E; Michel, J; Popon, M; Serreau, R; Sibony, O; Sobel, A	1
Glawe, JC; Hellyer, PW; Wagner, AE; Worland, GA	1

Reviews

2 review(s) available for ketoprofen and nalbuphine

Article	Year
Human UDP-glucuronosyltransferases: metabolism, expression, and disease. Annual review of pharmacology and toxicology, 2000, Volume: 40 Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic	2000
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Trials

2 trial(s) available for ketoprofen and nalbuphine

Article	Year
The urodynamic effects of intravenous opioids and ketoprofen in humans. Anesthesia and analgesia, 1998, Volume: 87, Issue:2 Topics: Adult; Analgesics, Opioid; Anti-Inflammatory Agents, Non-Steroidal; Buprenorphine; Fentanyl; Humans; Infusions, Intravenous; Ketoprofen; Male; Middle Aged; Morphine; Nalbuphine; Narcotic Antagonists; Urethra; Urinary Bladder; Urination; Urodynamics	1998
Multicenter, randomized controlled trial of pain-related behaviors following routine neutering in dogs. Journal of the American Veterinary Medical Association, 2008, Jul-01, Volume: 233, Issue:1 Topics: Analgesia; Animals; Behavior, Animal; Dogs; Female; Hysterectomy; Ketoprofen; Male; Morphine; Nalbuphine; Orchiectomy; Ovariectomy; Pain Measurement; Pain, Postoperative; Postoperative Care; Preoperative Care; Time Factors	2008

Article

Year

The urodynamic effects of intravenous opioids and ketoprofen in humans.

Anesthesia and analgesia, 1998, Volume: 87, Issue:2

Topics: Adult; Analgesics, Opioid; Anti-Inflammatory Agents, Non-Steroidal; Buprenorphine; Fentanyl; Humans; Infusions, Intravenous; Ketoprofen; Male; Middle Aged; Morphine; Nalbuphine; Narcotic Antagonists; Urethra; Urinary Bladder; Urination; Urodynamics

1998

Multicenter, randomized controlled trial of pain-related behaviors following routine neutering in dogs.

Journal of the American Veterinary Medical Association, 2008, Jul-01, Volume: 233, Issue:1

Topics: Analgesia; Animals; Behavior, Animal; Dogs; Female; Hysterectomy; Ketoprofen; Male; Morphine; Nalbuphine; Orchiectomy; Ovariectomy; Pain Measurement; Pain, Postoperative; Postoperative Care; Preoperative Care; Time Factors

2008

Other Studies

7 other study(ies) available for ketoprofen and nalbuphine

Article	Year
Hologram QSAR model for the prediction of human oral bioavailability. Bioorganic & medicinal chemistry, 2007, Dec-15, Volume: 15, Issue:24 Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship	2007
QSAR model for drug human oral bioavailability. Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13 Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship	2000
Surface activity profiling of drugs applied to the prediction of blood-brain barrier permeability. Journal of medicinal chemistry, 2004, Mar-25, Volume: 47, Issue:7 Topics: Blood-Brain Barrier; Lipid Bilayers; Micelles; Permeability; Pharmaceutical Preparations; Structure-Activity Relationship; Surface Properties	2004
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Physicochemical determinants of human renal clearance. Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15 Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight	2009
Excretion of ketoprofen and nalbuphine in human milk during treatment of maternal pain after delivery. Therapeutic drug monitoring, 2007, Volume: 29, Issue:6 Topics: Adult; Analgesics, Opioid; Anti-Inflammatory Agents, Non-Steroidal; Female; Humans; Ketoprofen; Milk, Human; Nalbuphine; Pain; Parturition; Postpartum Period	2007